Treatment of leishmaniasis with miltefosine: 2008 status
- PMID: 18721114
- DOI: 10.1517/17425255.4.9.1209
Treatment of leishmaniasis with miltefosine: 2008 status
Abstract
Background: Miltefosine is the first recognized oral treatment for leishmaniasis. It was first registered, in 2002, for Indian visceral leishmaniasis, and was reviewed by the present author in 2005.
Question: Miltefosine is now being used for the full range of clinical leishmaniasis. The present review addresses non-clinical and clinical advances since 2005.
Methods: PubMed was accessed for all articles on miltefosine from 2005 to 2008.
Results/conclusions: Miltefosine is effective and can be recommended for visceral disease in India and in Ethiopia, and for cutaneous disease in Colombia and Bolivia. For unusual forms of disease that require long periods of treatment such as diffuse cutaneous leishmaniasis and post-kala-azar dermal leishmaniasis, oral miltefosine is probably the treatment of choice.
Similar articles
-
[Miltefosine: a new remedy for leishmaniasis].Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2697-701. Ned Tijdschr Geneeskd. 2006. PMID: 17194005 Review. Dutch.
-
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.
-
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.Am J Trop Med Hyg. 2009 Mar;80(3):336-8. Am J Trop Med Hyg. 2009. PMID: 19270277
-
Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis.Clin Exp Dermatol. 2008 Jan;33(1):103-5. doi: 10.1111/j.1365-2230.2007.02547.x. Epub 2007 Nov 2. Clin Exp Dermatol. 2008. PMID: 17979988 No abstract available.
-
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.Trans R Soc Trop Med Hyg. 2006 Jul;100(7):698-700. doi: 10.1016/j.trstmh.2005.09.015. Epub 2005 Dec 2. Trans R Soc Trop Med Hyg. 2006. PMID: 16325873
Cited by
-
Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis.PLoS Negl Trop Dis. 2015 Feb 13;9(2):e0003476. doi: 10.1371/journal.pntd.0003476. eCollection 2015 Feb. PLoS Negl Trop Dis. 2015. PMID: 25679388 Free PMC article.
-
Design and synthesis of novel antileishmanial compounds.Int J Med Chem. 2015;2015:302723. doi: 10.1155/2015/302723. Epub 2015 Jan 21. Int J Med Chem. 2015. PMID: 25685554 Free PMC article.
-
Anticancer agents against malaria: time to revisit?Trends Parasitol. 2010 Mar;26(3):125-9. doi: 10.1016/j.pt.2009.12.002. Epub 2010 Jan 6. Trends Parasitol. 2010. PMID: 20056487 Free PMC article.
-
Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.Antimicrob Agents Chemother. 2010 Nov;54(11):4699-704. doi: 10.1128/AAC.00809-10. Epub 2010 Aug 16. Antimicrob Agents Chemother. 2010. PMID: 20713665 Free PMC article.
-
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.Med Chem Res. 2012 Oct;21(10):3080-3086. doi: 10.1007/s00044-011-9798-7. Epub 2011 Nov 11. Med Chem Res. 2012. PMID: 23024574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
